Track topics on Twitter Track topics that are important to you
OPN-375, in Development for Chronic Rhinosinusitis with and without Nasal Polyps, Demonstrated Statistically Significant Benefits in Patients with Nasal Polyps OptiNose...
OptiNose today announced that the company will present at the 2015 Annual International Nasal Drug Delivery (NDD) Conference – Advances in Drug Therapies, Systemic Delivery and ...
BeneChill’s lead product, the RhinoChill® System (“RhinoChill®), is a unique and patented medical device designed to deliver targeted and therapeutically effective coolin...
Perrigo Company plc announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun Pharma's Kenalog nasal spray. ...
(MedPage Today) -- Pharmaceutical company/NIDA seeking FDA approval for naloxone nasal spray
Zomig is the first nasal-delivered prescription medicine approved for the treatment of acute migraine attacks in pediatric patients. FDA Approvals
The Norwegian Institute of Public Health has been informed that a woman from Oslo died in December 2014 after returning from Thailand where she had been infected with the Naegleria fowleri amoeba. The...
Researchers have found that administering a nasal spray containing oxytocin led to men consuming less calories in a subsequent meal than those who received a placebo spray.
Effective O2 delivery and accurate end-tidal CO2 (ETCO2) sampling are essential features of nasal cannulae (NCs) in patients with compromised respiratory status. We studied 4 NC designs: bifurcated na...
Ketorolac tromethamine (KT) was potent to treat moderate to moderately severe pains. However, KT solutions for nasal delivery lost quickly from the nasal route. Thermo- and ion-sensitive in-situ hydro...
The nasal mucosa provides a potentially good route for local and systemic drug delivery. However, the protective feature of the nasal cavity make intranasal delivery challenging. The application of mu...
The objective of this investigation was the development of chitosan/xanthan polyelectrolyte complex based mucoadhesive nasal insert of promethazine hydrochloride a drug used in the treatment of motion...
The aim of the present study was to investigate the propensity of thiolated chitosan nanoparticles (TCNs) to enhance the nasal delivery of selegiline hydrochloride. TCNs were synthesized by the ionic ...